User profiles for "author:Pär-Ola Bendahl"

Pär-Ola Bendahl

Associate Professor, Lund University
Verified email at med.lu.se
Cited by 12374

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

MP Look, WLJ Van Putten, MJ Duffy… - Journal of the …, 2002 - academic.oup.com
Background: Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play
essential roles in tumor invasion and metastasis. High levels of both uPA and PAI-1 are …

[HTML][HTML] The CD44+/CD24-phenotype is enriched in basal-like breast tumors

G Honeth, PO Bendahl, M Ringnér, LH Saal… - Breast Cancer …, 2008 - Springer
Introduction Human breast tumors are heterogeneous and consist of phenotypically diverse
cells. Breast cancer cells with a CD44+/CD24-phenotype have been suggested to have …

Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity

LH Saal, P Johansson, K Holm… - Proceedings of the …, 2007 - National Acad Sciences
Pathway-specific therapy is the future of cancer management. The oncogenic
phosphatidylinositol 3-kinase (PI3K) pathway is frequently activated in solid tumors; …

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease

E Olsson, C Winter, A George, Y Chen… - EMBO molecular …, 2015 - embopress.org
Metastatic breast cancer is usually diagnosed after becoming symptomatic, at which point it
is rarely curable. Cell‐free circulating tumor DNA (ct DNA) contains tumor‐specific …

[HTML][HTML] CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers

E Olsson, G Honeth, PO Bendahl, LH Saal… - BMC cancer, 2011 - Springer
Background The CD44 cell adhesion molecule is aberrantly expressed in many breast
tumors and has been implicated in the metastatic process as well as in the putative cancer …

Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial

O Bjarnadottir, Q Romero, PO Bendahl… - Breast cancer research …, 2013 - Springer
Lipophilic statins purportedly exert anti-tumoral effects on breast cancer by decreasing
proliferation and increasing apoptosis. HMG-CoA reductase (HMGCR), the rate-limiting …

Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas

M Jönsson, J Dejmek, PO Bendahl, T Andersson - Cancer research, 2002 - AACR
Previous in vitro studies have implied that the Wnt-5a gene plays a role as a tumor
suppressor. To explore the clinical relevance of this concept, 96 primary invasive breast …

[HTML][HTML] Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential

P Francis, HM Namløs, C Müller, P Edén, J Fernebro… - BMC genomics, 2007 - Springer
Background Soft tissue sarcoma (STS) diagnosis is challenging because of a multitude of
histopathological subtypes, different genetic characteristics, and frequent intratumoral …

Estrogen receptor β expression is associated with tamoxifen response in ERα-negative breast carcinoma

SK Gruvberger-Saal, PO Bendahl, LH Saal… - Clinical Cancer …, 2007 - AACR
Purpose: Endocrine therapies, such as tamoxifen, are commonly given to most patients with
estrogen receptor (ERα)–positive breast carcinoma but are not indicated for persons with …

Should all patients with non–muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective …

S Gudjónsson, L Adell, F Merdasa, R Olsson… - European urology, 2009 - Elsevier
BACKGROUND: To decrease recurrences in non–muscle-invasive bladder cancer (NMIBC),
the European Association of Urology (EAU) guidelines recommend immediate, intravesical …